22:29 IST
NSE
Annual General Meeting
Gland Pharma Annual General Meeting
Gland Pharma Limited held its 48th Annual General Meeting on August 25, 2026. The company provided its proceedings and the Chairman's speech.
Gland Pharma Ltd
Gland Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹3,006.10
- Market cap
- ₹49,604 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 43.9×Sector 47.4×
- Promoter holding
- 51.77%-0.06% QoQ
- FII holding
- 8.74%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Management Change 6Earnings Call 6Employee Stock Options 4Board Meeting Outcome 4Other Announcement 3Legal & Regulatory 3Business Update 3Financial Results 2Results Update 1Promoter Selling 1Product Launch 1New Order Win 1Merger & Restructuring 1Capital Structure Change 1Capacity Expansion 1Board Meeting Date 1Acquisition 1
Time
7 announcements with these filters
20:09 IST
BSE
Annual General Meeting
Gland Pharma Annual General Meeting
Gland Pharma has issued a notice for its 48th Annual General Meeting to be held on August 25, 2026. The meeting agenda includes dividend declaration and director reappointments.
22:39 IST
NSE
Annual General Meeting
Gland Pharma Annual General Meeting
Gland Pharma Limited announced the results of the Postal Ballot, where all proposed resolutions regarding the appointment and remuneration of Independent Directors were passed.
18:25 IST
BSE
Annual General Meeting
Gland Pharma Annual General Meeting
Gland Pharma Limited announced the successful reappointment of Ms. Naina Lal Kidwai as an Independent Director through postal ballot. Shareholders approved the resolution with requisite majority.
14:26 IST
NSE
Annual General Meeting
Gland Pharma Annual General Meeting
Gland Pharma Limited clarified its postal ballot notice regarding Ms. Naina Lal Kidwai's reappointment. The company will obtain annual special resolutions from members if her remuneration exceeds 50% of the total Non-Executive Director pay for the FY 2026-2031 period.
- Execution
- FY 2026-27 to FY 2030-31
16:44 IST
NSE
Annual General Meeting
Gland Pharma Annual General Meeting
Gland Pharma Limited has issued a postal ballot notice to shareholders for the re-appointment of Ms. Naina Lal Kidwai as an Independent Director. The special resolution also proposes commission on profits as remuneration. Voting will be conducted virtually from April 14, 2026, to May 13, 2026.
16:43 IST
NSE
Annual General Meeting
Gland Pharma Annual General Meeting
Gland Pharma Limited has issued a postal ballot notice seeking shareholder approval to reappoint Ms. Naina Lal Kidwai as an Independent Director for a second five-year term starting May 17, 2026. The resolution includes a proposed commission of 0.25% on net profits, capped at ₹1 Crore annually. Remote e-voting remains open from April 14 to May 13, 2026.